CorneaGen
Pre-clinicalCTAK provides patient-ready, gamma-irradiated sterile, non-immunogenic donated corneal tissue inlays that are laser-cut and customized to patients’ specific severity and cone location.
Founded
2015
Focus
OphthalmologyRegenerative Medicine
About
CTAK provides patient-ready, gamma-irradiated sterile, non-immunogenic donated corneal tissue inlays that are laser-cut and customized to patients’ specific severity and cone location.
Funding History
3Total raised: $50M
Debt$10MSilicon Valley BankMar 15, 2022
Series B$25MUndisclosedSep 15, 2020
Series A$15MUndisclosedMay 15, 2018
Company Info
TypePrivate
Founded2015
LocationSeattle, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile